Sam Martin
Fortuna: 1 M $ al 31/05/2026
Fortuna: 1 M $ al 31/05/2026
Sam Martin currently works at Celldex Therapeutics, Inc. as CFO, Secretary, Treasurer & Senior Vice President since 2009.
Formerly, Mr. Martin was Director-Finance & Corporate Compliance at Alseres Pharmaceuticals, Inc. and Audit Manager at Ernst & Young LLP.
Education includes an MBA from Boston University and an undergraduate degree from Skidmore College.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/04/2026 | 32.942 ( 0,04 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CELLDEX THERAPEUTICS, INC. | Director Financiero/CFO | 01/04/2009 |
| Empresas | Cargo | Fin |
|---|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | - |
| ALSERES PHARMACEUTICALS, INC. | Director Financiero/CFO | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Alseres Pharmaceuticals, Inc.
Alseres Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and diagnostic products | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skidmore College
Skidmore College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.